Virus isolation and neutralisation of SARS-CoV-2 variants BA.2.86 and EG.5.1
Ria Lassaunière(Statens Serum Institut), Morten Rasmussen, Jannik Fonager(Statens Serum Institut), Henrik Ullum(Statens Serum Institut), Marc Stegger(Statens Serum Institut), Sharmin Baig(Statens Serum Institut), Pikka Jokelainen(Statens Serum Institut), Delphine Planas(Centre Hospitalier de l’Université de Montréal), Lene Nielsen(University of Southern Denmark), Kirsten Ellegaard(Statens Serum Institut), Olivier Schwartz(Centre National de la Recherche Scientifique), Etienne Simon‐Lorière(Institut Pasteur), Vithiagaran Gunalan(Statens Serum Institut), Marc Bennedbæk(Statens Serum Institut), Magdalena Utko(Statens Serum Institut), Tyra Grove Krause(Statens Serum Institut), Leandro Andrés Escobar-Herrera, Charlotta Polacek(Statens Serum Institut), Katja Spieß(University of Copenhagen), Anders Fomsgaard(Statens Serum Institut), Uffe Vest Schneider(Statens Serum Institut), Raphael N. Sieber(Statens Serum Institut), Karina M. Sørensen(Danmarks Nationalbank), Morten Hoppe(Gentofte Hospital)
Cited by 39
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Syncytia formation by SARS‐CoV‐2‐infected cells
|The EMBO Journal|2020|497
Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA homologue mecALGA251
|Clinical Microbiology and Infection|2011|429